Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Oskarsson

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Oncogene|November 3, 1998
Evidence for a role of Met-HGF/SF during Ras-mediated tumorigenesis/metastasisC P Webb, G A Taylor, M Jeffers, et al.
Cancer Research|February 10, 2000
The geldanamycins are potent inhibitors of the hepatocyte growth factor/scatter factor-met-urokinase plasminogen activator-plasmin proteolytic networkC P Webb, C D Hose, S Koochekpour, et al.
Heredity|November 24, 2011
Origins of domestic dog in southern East Asia is supported by analysis of Y-chromosome DNAZ-L Ding, M Oskarsson, A Ardalan, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 21, 2001
Neutralizing monoclonal antibodies to hepatocyte growth factor/scatter factor (HGF/SF) display antitumor activity in animal modelsB Cao, Y Su, M Oskarsson, et al.
Oncogene|July 1, 1990
An oncogenic chromosome 8-9 gene fusion isolated following transfection of human ovarian carcinoma cell line DNAD Halverson, W Modi, M Dean, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|July 1, 1993
Tumorigenesis induced by coexpression of human hepatocyte growth factor and the human met protooncogene leads to high levels of expression of the ligand and receptorS Rong, M Oskarsson, D Faletto, et al.
Oncogene|October 19, 1995
Mutagenic analysis of functional domains of the mos proto-oncogene and identification of the sites important for MAPK activation and DNA bindingK Fukasawa, R Zhou, W T Matten, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Oncogene|November 3, 1998
Evidence for a role of Met-HGF/SF during Ras-mediated tumorigenesis/metastasisC P Webb, G A Taylor, M Jeffers, et al.
Cancer Research|February 10, 2000
The geldanamycins are potent inhibitors of the hepatocyte growth factor/scatter factor-met-urokinase plasminogen activator-plasmin proteolytic networkC P Webb, C D Hose, S Koochekpour, et al.
Heredity|November 24, 2011
Origins of domestic dog in southern East Asia is supported by analysis of Y-chromosome DNAZ-L Ding, M Oskarsson, A Ardalan, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 21, 2001
Neutralizing monoclonal antibodies to hepatocyte growth factor/scatter factor (HGF/SF) display antitumor activity in animal modelsB Cao, Y Su, M Oskarsson, et al.
Oncogene|July 1, 1990
An oncogenic chromosome 8-9 gene fusion isolated following transfection of human ovarian carcinoma cell line DNAD Halverson, W Modi, M Dean, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|July 1, 1993
Tumorigenesis induced by coexpression of human hepatocyte growth factor and the human met protooncogene leads to high levels of expression of the ligand and receptorS Rong, M Oskarsson, D Faletto, et al.
Oncogene|October 19, 1995
Mutagenic analysis of functional domains of the mos proto-oncogene and identification of the sites important for MAPK activation and DNA bindingK Fukasawa, R Zhou, W T Matten, et al.
Pageof 3